Back to search results

Improving Decision-Making in Lung Cancer

This study is looking at how a special conversation tool can help people with lung cancer make decisions about their treatment. You would either use this tool, which is a type of decision aid (educational material to help you make choices), or receive the usual care. Researchers want to see if the conversation tool helps you understand your options better, feel more confident in your choices, and reduces any conflict you might feel about your decision. They will check these things up to 6 months after you start. This study is for adults aged 18 to 99 who are suspected of having lung cancer, speak English, and are expected to live for more than 6 months. The goal is to improve how patients, especially those who might have trouble understanding health information, make important treatment decisions.

Study design
This is an interventional study that plans to enroll 300 participants. You would be randomly assigned to one of two groups: either reviewing a decision aid or receiving standard care.
What's involved
You would either review a decision aid or receive standard care. Some participants will also have their clinic conversations recorded.
Compensation
Not stated in the trial record.
Follow-up
You would be followed up at 2 weeks, 3 months, and 6 months after the study intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05407168

Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool

Recruiting
NAAges 18–99InterventionalHealth services
OHSU Knight Cancer Institute
~300 participants
Updated 2026-06-25 on ClinicalTrials.gov
What's tested:Best PracticeHealth Promotion and EducationQuestionnaire Administration

At a glance

Recruiting sites
4 of 4 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Decision Conflict
Measured over Up to 6 months
+3 more outcomes measured

Conditions

Lung Carcinoma

Explore related trials

Lung Carcinoma

Where it's being run

4 sites across 1 states
Oregon4

Study leadership

  • Donald R Sullivan, MD, MA, MCR · PRINCIPAL_INVESTIGATOR · OHSU Knight Cancer Institute

Who to contact

Donald Sullivan, MD, MA, MCR
[email protected]
503-220-8262 · ext. 58087
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

AIM 1: Suspected lung cancer
AIM 1: English fluency
AIM 1: \> 6-month life expectancy
AIM 1: Score of ≥ 3 on the cognitive impairment screener
AIM 2 PARTICIPANTS: Participation in Aim 1
AIM 2 CLINICIANS: Discussing lung cancer treatment decisions with Aim 1 participants

What this trial measures

  • Decision ConflictUp to 6 months

    Will be assessed using the Decisional Conflict Scale, which contains 16 items. Higher scores indicate higher decisional conflict.

  • Efficacy of a conversation tool on patients' knowledge of lung cancerUp 6 months

    Will be assessed using nine questions from previously validated measures.

  • Satisfaction with Communication/Confidence in DecisionUp to 6 months

    Will be assessed using the 20-item COMRADE scale. Higher scores indicate better outcomes.

  • Self-EfficacyUp to 6 months

    Will be assessed using the Decision Self-Efficacy Scale which contains 11 items. Higher scores indicate higher self-efficacy.